CSF-Targeted Proteomics Indicate Amyloid-Beta Ratios in Patients with Alzheimer's Dementia Spectrum

BACKGROUND: According to recent studies, amyloid-β (Aβ) isoforms as cerebrospinal fluid (CSF) biomarkers have remarkable predictive value for cognitive decline in the early stages of Alzheimer's disease (AD). Herein, we aimed to investigate the correlations between several targeted proteomics i...

Descripción completa

Detalles Bibliográficos
Autores principales: Behzad, Maryam, Zirak, Negin, Madani, Ghazal Hamidi, Baidoo, Linda, Rezaei, Ali, Karbasi, Shima, Sadeghi, Mohammad, Shafie, Mahan, Mayeli, Mahsa, Alzheimer's Disease Neuroimaging Initiative
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925239/
https://www.ncbi.nlm.nih.gov/pubmed/36793451
http://dx.doi.org/10.1155/2023/5336273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925239/
https://www.ncbi.nlm.nih.gov/pubmed/36793451
http://dx.doi.org/10.1155/2023/5336273

Ejemplares similares